FTO and breast carcinoma: To investigate the molecular mechanism of FTO and identify its downstream targets in breast cancer, we performed transcriptome sequencing to examine the expression changes in our stable FTO-knockdown MDA-MB-231 cells (Additional file 4: Table S2) and MCF-7 cells treated with DMOG, a FTO inhibitor (GSE3188, Additional file 5: Table S3).